Related Experiment Video
Updated: Apr 17, 2026

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
Tuberculosis vaccines: barriers and prospects on the quest for a transformative tool
Christopher L Karp1, Christopher B Wilson, Lynda M Stuart
1Discovery and Translational Sciences, Global Health, The Bill & Melinda Gates Foundation, Seattle, WA, USA.
Developing a more effective tuberculosis vaccine is challenging but promising. Advances in understanding, new tools, diverse concepts, better models, and pragmatic trials offer hope for controlling this poverty-related disease.
Area of Science:
- Immunology
- Vaccinology
- Infectious Diseases
Background:
- Tuberculosis (TB) remains a major global health challenge, causing significant morbidity and mortality.
- Current TB vaccines have limitations in preventing adult pulmonary TB.
- Effective control requires novel strategies, including highly efficacious vaccines.
Purpose of the Study:
- To outline the current landscape and future directions for developing a more effective tuberculosis vaccine.
- To identify key advancements and challenges in TB vaccine research and development.
Main Methods:
- Review of conceptual clarity in TB immunopathogenesis.
- Assessment of novel tools for dissecting human TB.
- Evaluation of diverse TB vaccine concepts and candidate testing approaches.
- Analysis of fit-for-purpose animal models for TB vaccine evaluation.
Main Results:
- Significant progress in understanding TB immunobiology.
- Development of powerful new research tools and technologies.
- Increased diversity in TB vaccine strategies and design.
- Improved animal models and clinical trial methodologies.
Conclusions:
- Despite challenges, the field shows optimism for developing transformative TB vaccines.
- Advancements in basic science, technology, and trial design are paving the way for new TB control tools.
- Novel vaccines hold promise for reducing TB burden, particularly in impoverished communities.
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Vaccinations
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

